Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2014The Lancet OncologyOpen Access

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJ. Athene LaneUniversity of BristolJenny DonovanJenny DonovanUniversité Claude Bernard Lyon 1MDMichael DavisUniversity of Indianapolis

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lane et al. (2014) studied this question.

synapsesocial.com/papers/6a03c2d3d2f86d5a82f01d21https://doi.org/10.1016/s1470-2045(14)70361-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cancer statistics, 20132013 · 11,922 citations
  2. 2A Causal Proportional Hazards Estimator for the Effect of Treatment Actually Received in a Randomized Trial with All‐or‐Nothing Compliance2003 · 106 citations
  3. 3Multiple testing in clinical trials1991 · 243 citations
  4. 4The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology1993 · 16,277 citations
  5. 5Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)2014 · 30 citations